Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Vet Comp Oncol. 2013 May 15;13(3):246–254. doi: 10.1111/vco.12038

Figure 2.

Figure 2

Growth inhibition of canine neoplastic cell lines [including thyroid carcinoma (C-TAC), melanoma (CML-6M), mammary carcinoma (CMT-12), and osteosarcoma (D-17] following treatment with GS-424044 in C/10. Dividing cells were exposed for 72 h (A) or 5 d (B) to increasing concentrations of GS-424044. Cell viability was determined using the MTS assay. The percentage of growth was normalized to the control cells exposed to only C/10. Error bars represent the standard deviations calculated from four replicate experiments.